已核实 DOI 相关产品: 2

Injectable thermoresponsive carboxymethyl chitosan–hyaluronic acid hydrogel reinforced with mesoporous silica nanoparticles for efficient cationic drug delivery

Journal 2026 · IF 5.1 · 发表于 2026 年 3 月 23 日
作者: Toan Van Luu,Thavasyappan Thambi,Nghia T. Huynh,Bao H.G. Nguyen,Thanh-Nghi Do Ly,Yen-Nhi Pham Tran,Vy Khanh Huynh,Cuong Hung Luu,Diep Phan,Tuan Ngoc Nguyen,V.H.Giang Phan
阅读全文 在 PubMed 查看

摘要

Biological drugs face significant therapeutic hurdles due to their inherent instability and rapid systemic clearance. To address these challenges, this study developed a novel thermosensitive injectable hydrogel composed of carboxymethyl chitosan (CMCs), hyaluronic acid (HA), and β-glycerophosphate (GP). A key innovation involves the incorporation of mesoporous silica nanoparticles (MSNs) to create an organic–inorganic hybrid system (CMHGMs) with enhanced structural integrity and electrostatic affinity for cationic therapeutics. The results demonstrated that MSNs significantly optimised the network, reducing the gelation time from 2.7 min to approximately 1.4 min at 37 °C. Furthermore, the CMHGMs hydrogel exhibited superior sustained release profiles for lidocaine and lysozyme over 14 days, effectively suppressing the initial burst release. The system maintained excellent in vitro injectability through a 26G needle and showed high biocompatibility across in vitro , in ovo , and in vivo models. With a predicted biodegradation period of approximate 3.7 weeks, this hybrid hydrogel serves as a promising, minimally invasive drug depot for prolonged therapeutic delivery in modern clinical and biomedical applications.

本研究中使用的阿拉丁产品

2 款产品在本文中被引用